Linazasoro G - Search Results

1

Lewy bodies under atomic force microscope.

Tercjak A, Bergareche A, Caballero C, Tuñon T, Linazasoro G. Tercjak A, et al. Among authors: linazasoro g. Ultrastruct Pathol. 2014 Feb;38(1):1-5. doi: 10.3109/01913123.2013.825689. Epub 2013 Oct 17. Ultrastruct Pathol. 2014. PMID: 24134525

2

Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.

Morera-Herreras T, Ruiz-Ortega JA, Linazasoro G, Ugedo L. Morera-Herreras T, et al. Among authors: linazasoro g. Psychopharmacology (Berl). 2011 Mar;214(2):379-89. doi: 10.1007/s00213-010-2043-0. Epub 2010 Oct 20. Psychopharmacology (Berl). 2011. PMID: 20959968 Free PMC article.

3

Olfaction testing in PD: risky conclusions.

Linazasoro G. Linazasoro G. Mov Disord. 2008 May 15;23(7):1060. doi: 10.1002/mds.21572. Mov Disord. 2008. PMID: 17557341 No abstract available.

4

Potential applications of nanotechnologies to Parkinson's disease therapy.

Linazasoro G; Nanotechnologies for Neurodegenerative Diseases Study Group of the Basque Country (NANEDIS). Linazasoro G, et al. Parkinsonism Relat Disord. 2008;14(5):383-92. doi: 10.1016/j.parkreldis.2007.11.012. Epub 2008 Mar 7. Parkinsonism Relat Disord. 2008. PMID: 18329315 Review.

5

Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.

Linazasoro G. Linazasoro G. Eur J Neurol. 2007 Jul;14(7):721-8. doi: 10.1111/j.1468-1331.2007.01853.x. Eur J Neurol. 2007. PMID: 17594326 Review.

6

Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.

Bilbao G, Ruiz-Ortega JA, Miguens N, Ulibarri I, Linazasoro G, Gómez-Urquijo S, Garibi J, Ugedo L. Bilbao G, et al. Among authors: linazasoro g. Brain Res. 2006 Apr 21;1084(1):175-84. doi: 10.1016/j.brainres.2006.02.052. Epub 2006 Mar 30. Brain Res. 2006. PMID: 16574080

7

Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.

Grandoso L, Ponce S, Manuel I, Arrúe A, Ruiz-Ortega JA, Ulibarri I, Orive G, Hernández RM, Rodríguez A, Rodríguez-Puertas R, Zumárraga M, Linazasoro G, Pedraz JL, Ugedo L. Grandoso L, et al. Among authors: linazasoro g. Int J Pharm. 2007 Oct 1;343(1-2):69-78. doi: 10.1016/j.ijpharm.2007.05.027. Epub 2007 May 21. Int J Pharm. 2007. PMID: 17583454

8

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

Linazasoro G, Van Blercom N, Ugedo L, Ruiz Ortega JA. Linazasoro G, et al. J Neural Transm (Vienna). 2008;115(3):431-41. doi: 10.1007/s00702-007-0852-z. Epub 2008 Feb 4. J Neural Transm (Vienna). 2008. PMID: 18250954 Review.

9

Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.

Linazasoro G. Linazasoro G. Mov Disord. 2004 Jul;19(7):743-754. doi: 10.1002/mds.20120. Mov Disord. 2004. PMID: 15254931 Review.

10

Possible sporadic rapid-onset dystonia-parkinsonism.

Linazasoro G, Indakoetxea B, Ruiz J, Van Blercom N, Lasa A. Linazasoro G, et al. Mov Disord. 2002 May;17(3):608-9. doi: 10.1002/mds.10103. Mov Disord. 2002. PMID: 12112218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters